Patent Leaderboard
USPTO Patent Rankings Data through Sept 30, 2025
LP

Leonard G. Presta

Genentech: 125 patents #7 of 2,392Top 1%
Merck: 16 patents #667 of 9,382Top 8%
SCSchering: 15 patents #182 of 2,442Top 8%
COCompugen: 11 patents #24 of 181Top 15%
IBIgm Biosciences: 9 patents #3 of 16Top 20%
PMPierre Fabre Médicament: 5 patents #44 of 297Top 15%
PIPionyr Immunotherapeutics: 5 patents #1 of 14Top 8%
SRScripps Research: 4 patents #208 of 1,293Top 20%
ZYZymeworks: 3 patents #21 of 65Top 35%
INIntervet: 2 patents #101 of 311Top 35%
GSGilead Sciences: 2 patents #483 of 952Top 55%
SGSeattle Genetics: 1 patents #65 of 101Top 65%
CTCellerant Therapeutics: 1 patents #10 of 16Top 65%
XEXencor: 1 patents #72 of 104Top 70%
ZBZymeworks Bc: 1 patents #23 of 36Top 65%
SOSurrozen Operating: 1 patents #14 of 19Top 75%
ALAlector: 1 patents #25 of 34Top 75%
APAlexion Pharmaceuticals: 1 patents #110 of 226Top 50%
CACantargia Ab: 1 patents #12 of 16Top 75%
San Francisco, CA: #52 of 26,999 inventorsTop 1%
California: #464 of 386,348 inventorsTop 1%
Overall (All Time): #2,794 of 4,157,543Top 1%
216 Patents All Time

Issued Patents All Time

Showing 151–175 of 216 patents

Patent #TitleCo-InventorsDate
7005504 Antibody fragment-peg conjugates Vanessa Hsei, Iphigenia Koumenis, Steven Leong, Zahra Shahrokh, Gerardo Zapata 2006-02-28
6998253 Altered polypeptides with increased half-life Bradley R. Snedecor 2006-02-14
6914129 Anti-IgE antibodies Paula M. Jardieu 2005-07-05
6911321 Non-human primate Fc receptors and methods of use Angela Namenuk 2005-06-28
6897294 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production Terri Lynn Davis-Smyth, Helen Hsifei Chen, Napoleone Ferrara 2005-05-24
6870033 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies Vanessa Hsei, Iphigenia Koumenis, Steven Leong, Zahra Shahrokh, Gerarado A. Zapata 2005-03-22
6800738 Method for making humanized antibodies Paul Carter 2004-10-05
6761889 Anti-IgE antibodies Henry B. Lowman, Paula M. Jardieu, John Lowe 2004-07-13
6737056 Polypeptide variants with altered effector function 2004-05-18
6723833 Therapeutic compositions comprising anti-IGE antibodies and immunosuppressive agent Henry B. Lowman, Paula M. Jardieu, John Lowe 2004-04-20
6719971 Method for making humanized antibodies Paul Carter 2004-04-13
6703494 Anti-tissue factor antibodies with enhanced anticoagulant potency Daniel K. Kirchhofer, David G. Lowe 2004-03-09
6703018 Method of treatment using humanized anti-CD11a antibodies Paula M. Jardieu 2004-03-09
6699472 Method of treating allergic disorders Paula M. Jardieu 2004-03-02
6685939 Method of preventing the onset of allergic disorders Paula M. Jardieu 2004-02-03
6682735 Anti-IgE antibodies Henry B. Lowman, Paula M. Jardieu, John Lowe 2004-01-27
6639055 Method for making humanized antibodies Paul Carter 2003-10-28
6538124 Polypeptide variants Esohe Ekinaduese Idusogie, Michael George Mulkerrin 2003-03-25
6528624 Polypeptide variants Esohe Ekinaduese Idusogie, Michael George Mulkerrin 2003-03-04
6503728 Pantropic neurotrophic factors Roman Urfer, John W. Winslow 2003-01-07
6468532 Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates Vanessa Hsei, Iphigenia Koumenis, Steven Leong, Zahra Shahrokh, Gerardo Zapata 2002-10-22
6458355 Methods of treating inflammatory disease with anti-IL-8 antibody fragment-polymer conjugates Vanessa Hsei, Iphigenia Koumenis, Steven Leong, Zahra Shahrokh, Gerardo Zapata 2002-10-01
6407213 Method for making humanized antibodies Paul Carter 2002-06-18
6383486 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production Terri Lynn Davis-Smyth, Helen Hsifei Chen, Napoleone Ferrara 2002-05-07
6365373 Nucleic acids encoding NGF variants Roman Urfer, John W. Winslow 2002-04-02